Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PT-00114 by Protagenic Therapeutics for Substance (Drug) Abuse: Likelihood of Approval
PT-00114 is under clinical development by Protagenic Therapeutics and currently in Phase II for Substance (Drug) Abuse. According to GlobalData,...
PT-00114 by Protagenic Therapeutics for Generalized Anxiety Disorder (GAD): Likelihood of Approval
PT-00114 is under clinical development by Protagenic Therapeutics and currently in Phase II for Generalized Anxiety Disorder (GAD). According to...
PT-00114 by Protagenic Therapeutics for Treatment Resistant Depression: Likelihood of Approval
PT-00114 is under clinical development by Protagenic Therapeutics and currently in Phase II for Treatment Resistant Depression. According to GlobalData,...
PT-00114 by Protagenic Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
PT-00114 is under clinical development by Protagenic Therapeutics and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According to...
PT-00114 by Protagenic Therapeutics for Neurodegenerative Diseases: Likelihood of Approval
PT-00114 is under clinical development by Protagenic Therapeutics and currently in Phase II for Neurodegenerative Diseases. According to GlobalData, Phase...